What is the recommended dosage of Bactrim (trimethoprim/sulfamethoxazole) for a male patient with an uncomplicated urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For an adult male with an uncomplicated urinary tract infection, the recommended dosage of Bactrim (trimethoprim/sulfamethoxazole) is one double-strength tablet (containing 160 mg trimethoprim and 800 mg sulfamethoxazole) taken orally every 12 hours for 3 days, as supported by the most recent guidelines 1. This regimen is typically effective for eradicating the common bacterial pathogens that cause UTIs, particularly E. coli which is responsible for most cases. The medication works by inhibiting bacterial synthesis of folate, which is essential for DNA replication and bacterial growth. Some key points to consider when prescribing Bactrim for a male patient with an uncomplicated UTI include:

  • The patient should take the medication with a full glass of water and can take it with food if stomach upset occurs.
  • Adequate hydration should be maintained throughout treatment.
  • Common side effects may include nausea, vomiting, loss of appetite, and skin rash.
  • If severe side effects occur or symptoms worsen, medical attention should be sought immediately. It's also important to note that local resistance rates of uropathogens should be considered when choosing an antibiotic, and Bactrim should only be used if the resistance rate does not exceed 20% or if the infecting strain is known to be susceptible, as recommended by previous guidelines 1. However, the most recent guideline 1 provides the best practice advice for the treatment of uncomplicated UTIs, and its recommendations should be followed.

From the FDA Drug Label

Adults: The usual adult dosage in the treatment of urinary tract infections is 1 sulfamethoxazole and trimethoprim DS (double strength) tablet or 2 sulfamethoxazole and trimethoprim tablets every 12 hours for 10 to 14 days The recommended dosage of Bactrim (trimethoprim/sulfamethoxazole) for a male patient with an uncomplicated urinary tract infection (UTI) is:

  • 1 sulfamethoxazole and trimethoprim DS (double strength) tablet every 12 hours for 10 to 14 days
  • or 2 sulfamethoxazole and trimethoprim tablets every 12 hours for 10 to 14 days 2

From the Research

Bactrim Dosage for Male UTI

The recommended dosage of Bactrim (trimethoprim/sulfamethoxazole) for a male patient with an uncomplicated urinary tract infection (UTI) is not explicitly stated in the provided studies. However, the following information can be gathered:

  • A study from 1970 3 used a dosage of 160 mg of trimethoprim and 800 mg of sulfamethoxazole administered orally twice daily for 10 days to treat urinary tract infections.
  • A study from 1992 4 compared the efficacy of ciprofloxacin and trimethoprim-sulfamethoxazole (160 mg of trimethoprim and 800 mg of sulfamethoxazole twice daily for 10 days) in treating urinary tract infections.
  • The studies do not provide a specific recommendation for the dosage of Bactrim for male patients with UTI, but they do discuss the efficacy and resistance rates of trimethoprim-sulfamethoxazole in treating UTIs.

Considerations for Treatment

When considering treatment with Bactrim, the following points should be taken into account:

  • Resistance rates: The studies mention increasing resistance rates of E. coli to trimethoprim-sulfamethoxazole, which may affect the efficacy of treatment 5, 6.
  • Side effects: Bactrim can cause side effects, such as acute kidney injury, which has been reported in some studies 7.
  • Alternative treatments: Other antibiotics, such as fosfomycin, nitrofurantoin, or cefuroxime, may be considered as first-line treatments for lower UTIs due to their higher susceptibility rates 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.